Our Unique Structure
IVMT operates through strategic partnerships across four countries, integrating computational drug discovery, experimental virology, clinical expertise, and access to unique patient populations for tropical disease research.
Key Partner Institutions
Li Ka Shing Institute of Virology
Edmonton, AB, Canada
Canada's premier virology research institute, providing world-class experimental capabilities and clinical research infrastructure. IVMT is a center within LKSIoV, housed at the University of Alberta—one of Canada's top research universities.
Politecnico di Torino
Turin, Italy
One of Europe's leading technical universities, providing cutting-edge computational infrastructure and expertise in AI-driven drug discovery. Houses our Computational Drug Discovery Hub with high-performance computing and ML/AI development capabilities.
Open Source Medicine Americas
Prospera ZEDE, Bay Islands, Honduras
Provides access to tropical disease patient populations for research on diseases like Dengue, West Nile virus, and other emerging pathogens endemic to the region. Enables clinical studies in underserved populations with high disease burden.
How Our Partnership Works
Our multinational structure enables rapid iteration between computational prediction, experimental validation, and clinical translation:
- Discovery: Experimental teams identify biological targets and mechanisms
- Computation: Turin hub performs virtual screening and drug design
- Validation: Edmonton hub tests computational predictions
- Iteration: Results inform next round of computational optimization